Overview

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Status:
Completed

Trial end date:
2017-02-02

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to demonstrate non-inferiority of MENOPUR® versus recombinant Follicle Stimulating Hormone (rFSH) (Gonal-f®) with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation (COS) following GnRH treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Ferring Pharmaceuticals

Treatments:

Follicle Stimulating Hormone
Hormones
Menotropins